Skip to content

Research Categories

Cornea cover

EpiSmart® Crosslinking for Keratoconus: A Phase 2 Study


Randy J. Epstein, MD; Michael W. Belin, MD; Deborah Gravemann, RN, CCRP; Roxanne Littner, MS; and Roy S. Rubinfeld, MD, MA

Conclusion: This [FDA study reporting on 2,238 subjects] examined the response of patients with keratoconus to an “epi-on” CXL procedure using a novel technique… this represents a safer, noninvasive crosslinking to arrest the progression of keratoconus.